Amphastar’s Generic Quelicin Approved

June 10, 2020

The FDA has approved Amphastar’s generic of Pfizer’s Quelicin (succinylcholine chloride) 200mg/10ml multiple-dose vials for use as an adjunct to general anesthesia.

The injectable solution is used to relax the muscles during surgery or medical procedures, such as intubation or mechanical ventilation.

California-based Amphastar is focused primarily on developing injectable, inhalation and intranasal products for hospital or urgent care settings.

View today's stories